🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
Mantle Cell Lymphoma (MCL) is a form of Non-Hodgkin Lymphoma (NHL - cancer ...
Status
Completed
Location
NHO Nagoya Medical Center /ID# 221958
Start Date
2020-09-23
Trial ID
NCT04477486
Treatments Being Tested
An observational study to assess the effectiveness, health economic-relevan...
Status
Recruiting
Location
Universitaetsklinikum St. Poelten /ID# 221152
Start Date
2017-12-04
Trial ID
NCT03342144
A recent study showed that 6 cycles of obinutuzumab when given after at lea...
Status
Active Not Recruiting
Location
DK-Aalborg-AALBORGUH
Start Date
2020-12-29
Trial ID
NCT04639362
Treatments Being Tested
This Phase 3 multinational, randomized, double-blind study is designed to c...
Status
Completed
Location
The University of Arizona Cancer Centre-North Campus
Start Date
2017-06-19
Trial ID
NCT03112174
Treatments Being Tested
Safety, pharmacokinetics, and preliminary efficacy of CC-122 alone and in c...
Status
Completed
Location
University of California San Diego
Start Date
2015-07-27
Trial ID
NCT02406742
Treatments Being Tested
This phase II trial studies how well ibrutinib and rituximab given together...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-05-01
Trial ID
NCT03710772
Venetoclax and ibrutinib have complementary activity in clearing the diseas...
Status
Terminated
Location
Kantonsspital Aarau
Start Date
2019-03-11
Trial ID
NCT03708003
Treatments Being Tested
This phase Ib/II trial studies the best dose and safety of Bcl-2 inhibitor ...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2015-08-03
Trial ID
NCT02427451
This is a Phase 2, multicenter, open-label uncontrolled interventional stud...
Status
Recruiting
Location
IRCCS Ospedale San Raffaele
Start Date
2022-09-19
Trial ID
NCT04758975
Treatments Being Tested